A clinical experience with the NCGT graft
โ Scribed by Reddy, K. ;Haque, S. N. ;Cohen, L. ;Sophie, Z. ;Feller, J. ;Stillman, R. M. ;Fitzgerald, J. ;Stanczewski, B. ;Sawyer, P. N.
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 368 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0021-9304
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
A comparison of 130 grafts done in 101 patients included 47 veins, 25 Johnson & Johnson dialdehydeโstarchโtanned collagen prostheses, and 58 NCGT grafts that had been followed for a 40โmonth period. This study had documented the fact that in spite of frequent poor runoff, a useful result is provided by the NCGT graft apparently due in part to its builtโin nonthrombogenic structure providing a cumulative patency of 73%. The patency rate was even superior with venous bypasses. Therefore, we still feel that the autogenous vein provides the most useful bypass conduit available in vascular reconstruction. In situations where a vein could not be used or was not available the NCGT graft offers an equally useful nonthrombogenic surface to maintain prolonged patency. Thus, collagen appropriately modified can provide a useful prosthesis in vascular reconstruction.
๐ SIMILAR VOLUMES
Coating stents with autologous venous grafts has been suggested to prevent problems associated with conventional stenting, but the need for surgical vessel harvest hampered broad application. A novel synthetic coronary stent graft (CSG) overcomes this limitation by a synthetic membrane, fixed betwee
Because of the logistical and practical problems that make cancer prevention trials using cancer incidence as an endpoint virtually impossible to conduct for the majority of cancer types, there is a desperate need for valid intermediate markers of cancer risk to serve as surrogate endpoints in chemo